Home Picks Investors Groups Discuss! Research

Search

Sign Up   |   Log In   |   What is SocialPicks?

Please sign up for SocialPicks site access - it's free!

Kiva lets you connect with and loan money to unique small businesses in the developing world. By choosing a business on Kiva.org, you can "sponsor a business" and help the world's working poor make great strides towards economic independence. Throughout the course of the loan (usually 6-12 months), you can receive email journal updates from the business you've sponsored. As loans are repaid, you get your loan money back. Created by Brennan Woods Which stock would you like to ask your group members about? Symbol Home Discuss Picks Members          Discuss within Kiva Lenders + Start a new discussion No recent discussion has been posted within Kiva Lenders. ROCK-STAR INVESTORS Rank Name Sharpe Ratio Avg Return Followers 1 noshoes 21.10 +34.37% 379 2 Gerald Greene 18.14 +70.70% 208 3 stockmarketfunding.com 17.66 +25.67% 55 4 akiralegrand 13.47 +14.32% 61 5 anup2104 12.13 +78.05% 38 ... more »    POPULAR STOCKS Symbol Company Name Sentiment ETFC E*Trade Financial Corp EBAY eBay Inc KO The CocaCola Company BAC Bank of America Corp AAPL Apple Computer Inc LEH Lehman Brothers Holdings Inc ... more »    TODAY'S HEADLINES LDK Solar's Growth Potential Offset by Gross Margin Pressure    by Paul Cheung (Zacks.com)  about LDK Cisco Systems Still a Wait and See    by Thomas Catino (Ant & Sons)  about CSCO The Merrill Lynch Diet: Starving Shareholders    by Zack Miller (BloggingStocks)  about MER Until Housing Improves, Don't Expect Stocks to Rebound    by J.D. Steinhilber (Agile Investing)  about SPY Google Blows Q2: Multiple Compression to Continue    by Henry Blodget  about GOOG ... more »    TODAY'S TOP PICKS ABIO BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla NVO Diabetes Care: Global Investing Opportunities by Mike Havrilla DNDN BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen by Mike Havrilla ONCY Oncolytics Biotech Inc. down to 2,00 $ by Yannis Maarten JNJ Epinex Diagnostics: A New Paradigm for Diabetic Testing by Mike Havrilla ... more »

Share this:   MEMBERS RANKING Name Percentile Return Followers chadiusdarwin 95% +37.92% 0 igotwoods 63% +58.58% 0 metavalent stigmergy 49% -8.88% 3 Roomy Naqvy 39% -3.29% 1 Brennan Woods 35% +5.33% 26 Shilpa 27% -11.07% 2 John Manoogian 26% -10.64% 0 Candid Consultancy 25% -10.69% 0 Steven S 17% -20.16% 0 24racinraiders 17% -24.39% 0 View All Members » TODAY'S HEADLINES LDK Solar's Growth Potential Offset by Gross Margin Pressure    by Paul Cheung (Zacks.com)  about LDK Cisco Systems Still a Wait and See    by Thomas Catino (Ant & Sons)  about CSCO The Merrill Lynch Diet: Starving Shareholders    by Zack Miller (BloggingStocks)  about MER Until Housing Improves, Don't Expect Stocks to Rebound    by J.D. Steinhilber (Agile Investing)  about SPY Google Blows Q2: Multiple Compression to Continue    by Henry Blodget  about GOOG ... more »

IN THE PRESS

About  |   RSS  |   Feedback  |   Contact Us  |   Terms of Service  |   Privacy

© 2009 FinancialContent Services, Inc.

Data powered by FinancialContent.  All Rights Reserved.   Quotes delayed at least 20 minutes unless otherwise indicated.

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.